Elif Atağ

Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Patients with Neuroendocrine Tumors: An Izmir Oncology Group Study

Tarık Salman, Seher Nazlı Kazaz, Umut Varol et al. · Chemotherapy · 2016 · 60 citations

The effect of low HER2 expression on treatment outcomes in metastatic hormone receptor positive breast cancer patients treated with a combination of a CDK4/6 inhibitor and endocrine therapy: A multicentric retrospective study

Elif Atağ, Ezgi Çoban, Olçun Ümit Ünal et al. · The Breast · 2023 · 17 citations · Full text

Factors influencing physical activity in patients with colorectal cancer

Dilek Küçükvardar, Didem Karadibak, İsmail Özsoy et al. · Irish Journal of Medical Science (1971 -) · 2020 · 16 citations

Physical Activity, Exercise, Exercise Physiology +5

Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab

Deniz Tural, Ömer Fatih Ölmez, Ahmet Taner Sümbül et al. · International Journal of Clinical Oncology · 2021 · 16 citations

Prognostic Factors, Urology, Surgical Oncology +7

Prevalence of depressive symptoms in elderly cancer patients receiving chemotherapy and influencing factors

Elif Atağ, Feyza Mutlay, Pınar Soysal et al. · Psychogeriatrics · 2018 · 12 citations